EE200300294A - Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod - Google Patents

Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod

Info

Publication number
EE200300294A
EE200300294A EEP200300294A EEP200300294A EE200300294A EE 200300294 A EE200300294 A EE 200300294A EE P200300294 A EEP200300294 A EE P200300294A EE P200300294 A EEP200300294 A EE P200300294A EE 200300294 A EE200300294 A EE 200300294A
Authority
EE
Estonia
Prior art keywords
preparation
sulfonamide substituted
substituted imidazotriazinones
imidazotriazinones
sulfonamide
Prior art date
Application number
EEP200300294A
Other languages
English (en)
Inventor
Nowakowski Marc
Gehring Reinhold
Heilmann Werner
Wahl Karl-Heinz
Original Assignee
Bayer Aktiengeshellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengeshellschaft filed Critical Bayer Aktiengeshellschaft
Publication of EE200300294A publication Critical patent/EE200300294A/et
Publication of EE05308B1 publication Critical patent/EE05308B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
EEP200300294A 2000-12-18 2001-12-05 Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod EE05308B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10063108A DE10063108A1 (de) 2000-12-18 2000-12-18 Verfahren zur Herstellung von Sulfonamid-substituierten Imidazotriazinonen
PCT/EP2001/014239 WO2002050076A2 (de) 2000-12-18 2001-12-05 Verfahren zur herstellung von sulfonamid-substituierten imidazotriazinonen

Publications (2)

Publication Number Publication Date
EE200300294A true EE200300294A (et) 2003-10-15
EE05308B1 EE05308B1 (et) 2010-06-15

Family

ID=7667666

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300294A EE05308B1 (et) 2000-12-18 2001-12-05 Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod

Country Status (43)

Country Link
US (3) US6777551B2 (et)
EP (1) EP1345939B1 (et)
JP (1) JP4441175B2 (et)
KR (1) KR100787288B1 (et)
CN (1) CN1227253C (et)
AR (1) AR032775A1 (et)
AT (1) ATE328885T1 (et)
AU (2) AU1708902A (et)
BG (1) BG66142B1 (et)
BR (1) BRPI0116227B8 (et)
CA (1) CA2431933C (et)
CU (2) CU23341B7 (et)
CY (1) CY1105197T1 (et)
CZ (1) CZ297005B6 (et)
DE (2) DE10063108A1 (et)
DK (1) DK1345939T3 (et)
DO (1) DOP2001000295A (et)
EC (1) ECSP034657A (et)
EE (1) EE05308B1 (et)
ES (1) ES2266098T3 (et)
GT (1) GT200100251A (et)
HK (1) HK1063799A1 (et)
HN (1) HN2001000278A (et)
HR (1) HRP20030583B1 (et)
HU (1) HU229296B1 (et)
IL (2) IL156278A0 (et)
MA (1) MA25927A1 (et)
MX (1) MXPA03005429A (et)
MY (1) MY126689A (et)
NO (1) NO325398B1 (et)
NZ (1) NZ526477A (et)
PE (1) PE20020590A1 (et)
PL (1) PL207294B1 (et)
PT (1) PT1345939E (et)
RU (1) RU2299211C2 (et)
SI (1) SI1345939T1 (et)
SK (1) SK286894B6 (et)
SV (1) SV2003000766A (et)
TW (1) TWI289562B (et)
UA (1) UA75109C2 (et)
UY (2) UY27070A1 (et)
WO (1) WO2002050076A2 (et)
ZA (1) ZA200304705B (et)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10063108A1 (de) * 2000-12-18 2002-06-20 Bayer Ag Verfahren zur Herstellung von Sulfonamid-substituierten Imidazotriazinonen
DE10107639A1 (de) * 2001-02-15 2002-08-22 Bayer Ag 2-Alkoxyphenyl-substituierte Imidazotriazinone
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
DE202004006552U1 (de) * 2004-04-26 2004-07-08 Knürr AG Kühlungssystem für Geräte- und Netzwerkschränke
DE102004023069A1 (de) 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
US7977478B2 (en) * 2006-03-13 2011-07-12 Dr. Reddy's Laboratories Limited Polymorphic forms of vardenafil
WO2009030095A1 (en) * 2007-09-06 2009-03-12 Topharman Shanghai Co., Ltd. Process for preparing vardenafil and its intermediates
ES2388371T3 (es) 2007-12-28 2012-10-15 Topharman Shanghai Co., Ltd. N-{1-[3-(2-etoxi-5-(4-etilpiperazinil)bencenosulfonil)-4,5-dihidro-5-oxo-1,2,4-triazin-6-il]etil}-butiramida, método de preparación y uso
EP2462127A1 (en) 2009-08-07 2012-06-13 Ranbaxy Laboratories Limited Processes for the preparation of vardenafil
PL390079A1 (pl) * 2009-12-30 2011-07-04 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób otrzymywania wardenafilu i jego izolacji jako soli z kwasem cytrynowym oraz krystaliczna postać tej soli
CN102134242B (zh) 2011-01-21 2013-08-28 浙江大德药业集团有限公司 一种用于治疗阳痿的快速长效的化合物
CZ303877B6 (cs) * 2011-11-24 2013-06-05 Zentiva, K.S. Zpusob prípravy a izolace solí vardenafilu s kyselinami
US20160317542A1 (en) 2013-12-09 2016-11-03 Respira Therapeutics, Inc. Pde5 inhibitor powder formulations and methods relating thereto
PL223869B1 (pl) 2013-12-16 2016-11-30 Starogardzkie Zakłady Farm Polpharma Spółka Akcyjna Sposób otrzymywania wardenafilu i jego soli
CN107383020A (zh) * 2017-07-29 2017-11-24 合肥创新医药技术有限公司 一种伐地那非杂质的制备方法
JP2021506986A (ja) 2017-12-20 2021-02-22 クラリア・ファルマ・ホールディング・アクチボラグ バルデナフィルを含むフィルム配合物、その調製法、およびその使用
CN115043757B (zh) * 2022-07-27 2023-08-08 南京桦冠生物技术有限公司 一种连续化制备苄脒盐酸盐的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
UA46166C2 (uk) 1997-11-12 2002-05-15 Баєр Акцієнгезельшафт 2-фенілзаміщені імідазотриазинони як інгібітори фосфодіестерази, спосіб їх одержання та лікарський засіб на їх основі
DE10063108A1 (de) * 2000-12-18 2002-06-20 Bayer Ag Verfahren zur Herstellung von Sulfonamid-substituierten Imidazotriazinonen
DE10107639A1 (de) * 2001-02-15 2002-08-22 Bayer Ag 2-Alkoxyphenyl-substituierte Imidazotriazinone

Also Published As

Publication number Publication date
MXPA03005429A (es) 2004-05-04
BR0116227B1 (pt) 2014-08-26
DE50110080D1 (de) 2006-07-20
HUP0302467A3 (en) 2004-11-29
EP1345939A2 (de) 2003-09-24
ECSP034657A (es) 2003-07-25
PE20020590A1 (es) 2002-07-13
DK1345939T3 (da) 2006-09-25
SK7502003A3 (en) 2003-10-07
RU2299211C2 (ru) 2007-05-20
US20050014756A1 (en) 2005-01-20
CN1481386A (zh) 2004-03-10
PL365310A1 (en) 2004-12-27
SV2003000766A (es) 2003-01-13
NO20032731D0 (no) 2003-06-16
AU1708902A (en) 2002-07-01
US6998483B2 (en) 2006-02-14
HU229296B1 (en) 2013-10-28
PL207294B1 (pl) 2010-11-30
NO20032731L (no) 2003-06-16
HRP20030583A2 (en) 2005-06-30
US6777551B2 (en) 2004-08-17
CA2431933C (en) 2009-12-01
BG66142B1 (bg) 2011-07-29
UY37172A (es) 2017-06-30
GT200100251A (es) 2002-10-01
AR032775A1 (es) 2003-11-26
BRPI0116227B8 (pt) 2021-05-25
CY1105197T1 (el) 2010-03-03
ATE328885T1 (de) 2006-06-15
CU23873B1 (es) 2013-04-19
BR0116227A (pt) 2003-12-30
DE10063108A1 (de) 2002-06-20
ZA200304705B (en) 2004-08-12
US20020137930A1 (en) 2002-09-26
CZ297005B6 (cs) 2006-08-16
CU23341B7 (es) 2009-02-20
JP2004517849A (ja) 2004-06-17
CU20080213A7 (es) 2012-06-21
HRP20030583B1 (en) 2011-09-30
HK1063799A1 (en) 2005-01-14
BG107892A (bg) 2004-08-31
UY27070A1 (es) 2002-07-31
ES2266098T3 (es) 2007-03-01
KR20030063430A (ko) 2003-07-28
NO325398B1 (no) 2008-04-21
HUP0302467A2 (hu) 2003-11-28
WO2002050076A3 (de) 2002-08-29
IL156278A0 (en) 2004-01-04
PT1345939E (pt) 2006-08-31
AU2002217089B2 (en) 2006-01-12
HN2001000278A (es) 2002-01-30
EE05308B1 (et) 2010-06-15
EP1345939B1 (de) 2006-06-07
KR100787288B1 (ko) 2007-12-20
DOP2001000295A (es) 2002-12-15
MY126689A (en) 2006-10-31
CA2431933A1 (en) 2002-06-27
SK286894B6 (sk) 2009-07-06
NZ526477A (en) 2004-12-24
MA25927A1 (fr) 2003-10-01
SI1345939T1 (sl) 2006-10-31
IL156278A (en) 2009-06-15
CZ20031692A3 (cs) 2003-10-15
UA75109C2 (en) 2006-03-15
WO2002050076A2 (de) 2002-06-27
TWI289562B (en) 2007-11-11
CN1227253C (zh) 2005-11-16
JP4441175B2 (ja) 2010-03-31
US20050203298A1 (en) 2005-09-15

Similar Documents

Publication Publication Date Title
CY2007029I1 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
FI20011578A0 (fi) Menetelmä puhtaan sitalopraamin valmistamiseksi
FI20011621A (fi) Menetelmä sitalopraamin valmistamiseksi
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
EE200300294A (et) Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod
NO20030163L (no) Fremgangsmate for fremstilling av olefiner
NO20040027L (no) Fremgangsmate for fremstillingen av escitalopram
FI20011889A0 (fi) Menetelmä ksylitolin valmistamiseksi
NO20025423L (no) Fremgangsmate for fremstilling av Citalopram
NO20026155L (no) Fremgangsmåte for fremstilling av lavere olefiner
NO20021118D0 (no) Fremgangsmåte for fremstilling av citalopram
NO20025533D0 (no) Sulfonamidderivater
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
NO20025459L (no) Sulfonamidderivater
AR028328A1 (es) Proceso para la preparacion de heterociclos benzo-fusionados
NO20023702D0 (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
ITRM20000644A0 (it) Procedimento per la fabbricazione di stampi.
NO20025385L (no) Fremgangsmate for fremstilling av sulfonylbenzoylguanidiniumsalter
ITMI20000261A0 (it) Processo per la preparazione di piridiniliden-ftalidi
AR028111A1 (es) Procedimiento para la produccion de isocianatos
ITMI20000334A0 (it) Procedimento di preparazione di miscele cementizie
FI20000535A0 (fi) Menetelmä kuparin valmistamiseksi
ITMI20012131A0 (it) Procedimento per la preparazione di alo-benzonitrili

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20101231

GB1A Change in the ownership or in the address of the owner